e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Quality of diagnosis and assessment in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Using population insight studies to define effective prevention and identification interventions in COPD
M. Kearney, J. Crighton, K. Holton, A. Moger, R. Winter, S. Hill (London, United Kingdom)
Source:
Annual Congress 2011 - Quality of diagnosis and assessment in primary care
Session:
Quality of diagnosis and assessment in primary care
Session type:
Thematic Poster Session
Number:
3762
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kearney, J. Crighton, K. Holton, A. Moger, R. Winter, S. Hill (London, United Kingdom). Using population insight studies to define effective prevention and identification interventions in COPD. Eur Respir J 2011; 38: Suppl. 55, 3762
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Population segmentation to identify priority targets for identification and behaviour change interventions in COPD
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017
The impact of a new recruitment strategy to improve recruitment of participants to research studies
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
A survey of the multidisciplinary team‘s knowledge of the management of patients with COPD, in order to help identify future training needs
Source: Annual Congress 2009 - Medical education
Year: 2009
Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Source: Breathe, 17 (4) 210118; 10.1183/20734735.0118-2021
Year: 2021
A competence framework to support the development of the workforce to deliver improved outcomes for patients with COPD and asthma
Source: Annual Congress 2012 - Professional development and advanced practice roles in respiratory nursing
Year: 2012
Lifestyle interventions in prevention and comprehensive management of COPD
Source: Breathe, 14 (3) 186; 10.1183/20734735.018618
Year: 2018
What are the knowledge gaps in COPD that prevent new drug development?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Identifying tools to investigate outcomes following an exacerbation of COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
(Non-)sense to interpret meta-analyses with heterogeneous interventions: the example of non-pharmacological interventions
Source: International Congress 2015 – How to perform and interpret systematic reviews and meta-analyses
Year: 2015
Halotherapy and Covid-19: an oppinion for a possible future prevention approach
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021
Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study
Source: International Congress 2019 – M-health/e-health II
Year: 2019
Identifying inconsistencies in intervention descriptors and outcome reporting within systematic reviews of physical activity interventions in COPD
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis
Source: Eur Respir J 2016; 48: 55-68
Year: 2016
A UK population perspective - active intervention and evidence based advice can improve symptom control in asthma
Source: Annual Congress 2004 - Primary care: asthma
Year: 2004
The consequences of novel insights into the pathophysiology of asthma for its treatment
Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease?
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept